Tridol

Quick links to important sections

Tridol

Treatment option: Pain, Chronic Pain

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tridol

What is Tridol? A Quick Overview

Property Description
Active ingredient Tramadol Hydrochloride
Form Tablet, Capsule, Oral Solution, Injection
Pharmacological class Centrally Acting Opioid Analgesic
Common use Management of moderate to moderately severe pain
Origin Synthetic

What is Tridol and What is Its Active Ingredient?

Tridol is a pharmaceutical preparation containing Tramadol Hydrochloride as its active ingredient, and it is classified as a prescription-only medicine primarily used for the management of moderate to moderately severe pain. Tramadol is chemically categorized as a synthetic opioid analgesic that works centrally within the nervous system. The substance itself is a racemic mixture of two enantiomers, (+) and (-) Tramadol, which both contribute to its overall therapeutic effect.


What Type of Analgesic is Tramadol Hydrochloride?

Tramadol Hydrochloride is characterized as a centrally acting analgesic due to its unique dual mechanism of action. It acts as an analgesic and weak inhibitor of monoamine reuptake, reflecting its chemical complexity. Its mechanism involves the substance and its active metabolite, O-desmethyl-tramadol (M1 metabolite), acting as an opioid agonist at the mu-opioid receptors, while also serving as a weak Serotonin–Norepinephrine Reuptake Inhibitor (SNRI). This dual mechanism provides a comprehensive analgesic effect particularly useful for managing discomfort that is not adequately controlled by other non-opioid medications.


What Forms of Tridol Are Available?

The drug is available in several dosage form(s) to suit various patient needs. These preparations commonly include immediate-release tablets and capsules for the standard oral route of administration. For long-term pain management, extended-release tablets and capsules are formulated to release the medication slowly over a prolonged period. Furthermore, the drug is available as a solution for injection (intravenous or intramuscular) and as a suppository for rectal administration when the oral route is not appropriate or immediate relief is required.

What side effects are possible with Tridol?

Possible Side Effects and Safety Information

The official safety profile for Tridol (Tramadol Hydrochloride) details adverse reactions across various body systems, which are formally categorized by frequency and system-organ class in regulatory documentation such as the EMA Summary of Product Characteristics (SmPC) and FDA Prescribing Information.

Frequency-Classified Adverse Reactions

The incidence of adverse reactions is defined using standard regulatory frequency categories:

  • Very Common (occurs in ge 1/10 patients): Nausea, Dizziness.
  • Common (occurs in ge 1/100 to < 1/10 patients): Vomiting, Constipation, Dry mouth, Headache, Somnolence (drowsiness), Sweating, Fatigue.
  • Uncommon (occurs in ge 1/1,000 to < 1/100 patients): Diarrhoea, gastrointestinal discomfort, Pruritus, Rash, Cardiovascular effects like postural hypotension.
  • Rare (occurs in ge 1/10,000 to < 1/1,000 patients): Seizures, Confusion, Hallucinations, Respiratory depression, Allergic reactions (including anaphylaxis).

Serious Adverse Reactions and Safety Constraints

The label explicitly identifies several serious adverse events, including the risk of Respiratory depression, Serotonin syndrome, and Seizures. Tolerance, physical and psychological dependence, and withdrawal symptoms may develop, particularly with long-term use, and are associated with abrupt discontinuation. Adverse reactions like nausea and dizziness are noted to be most frequent at the start of treatment.

Safety is addressed through constraints that limit use in specific conditions. The medication is contraindicated in children younger than 12 years of age and in cases of acute intoxication with CNS depressants. Caution and potential dosage adjustment are noted for individuals with severe renal or hepatic impairment and older adults.

Overdose and Emergency Response

Overdose and When to Seek Help

A known or suspected overdose with Tridol (Tramadol Hydrochloride) constitutes a life-threatening medical emergency and requires immediate professional medical attention. This imperative applies regardless of the quantity ingested due to the severe, documented risks.

Seek Emergency Help Immediately:

  • Contact emergency services for any signs of overdose, including profound sedation, unresponsiveness, or compromised breathing (respiratory depression).
  • Accidental ingestion of even a single dose by a child is formally documented as potentially fatal and requires urgent hospitalization.

Documented Clinical Manifestations: Overdose primarily results in CNS and respiratory system effects. Manifestations documented in regulatory labeling include:

  • The most critical sign is life-threatening respiratory depression, leading to coma and sometimes cardiac arrest.
  • Seizures (convulsions) and the potentially fatal complication of Serotonin Syndrome are also formally associated with overdose.
  • Other severe signs can include circulatory shock and miosis.

Emergency Management Notes: The documented management prioritizes securing the airway and providing assisted ventilation. Naloxone is the specific antidote for respiratory depression; however, regulatory warnings note its use may carry an increased risk of seizures and may not reverse all symptoms. Prolonged hospital monitoring is necessary, as hemodialysis is not effective for drug removal.

Therapeutic Uses of Tridol

This medication is generally used in situations where physical discomfort is more pronounced and where additional symptomatic support is sought. Tridol is applied across therapeutic domains primarily supporting the easing of distress and contributing to comfort for pain reaching moderate to moderately severe intensity.

This medication is relevant in conditions characterized by persistent musculoskeletal pain, such as chronic low back pain or discomfort from osteoarthritis, as well as during acute symptomatic episodes like the recovery phase after major surgery or following significant physical trauma. It may offer symptomatic relief when other non-opioid approaches have been insufficient for symptom management.

“Tridol is used in clinical settings where symptoms interfere with daily functioning and create noticeable physiological strain.”

This supportive relief may assist with maintaining functional stability and may contribute to comfort during these periods of heightened symptoms.


Quick Fact: Relief for Moderate to Moderately Severe Pain Tridol is often applied during phases when pain intensity is substantial enough that symptoms may intensify temporarily and interfere with daily functioning, which may provide supportive relief when symptoms interfere with functional stability.

Regulatory References

  1. NIH MedlinePlus Drug Information on Tramadol

Eligibility and Restrictions for Use

Who Can and Cannot Use Tridol?

Eligibility for Tridol (Tramadol Hydrochloride) is strictly defined by regulatory documents based on age, concurrent medical conditions, and physiological status.

Contraindicated Populations

Tridol is contraindicated and must not be used by specific groups, including:

  • Children younger than 12 years of age.
  • Patients with a known history of hypersensitivity to tramadol or opioids.
  • Individuals with significant respiratory depression or acute, severe bronchial asthma.
  • Patients concurrently taking Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of stopping them.

Restricted and Conditional Use

Some populations require strict limitations or caution:

  • Adolescents (12 to 18 years): Contraindicated following tonsillectomy/adenoidectomy; use should be avoided in those with risk factors like obstructive sleep apnea.
  • Organ Function: Use of extended-release forms is not recommended in patients with severe renal impairment (creatinine clearance < 30 mL/min) or severe hepatic impairment.
  • Pregnancy and Lactation: Use is not recommended during pregnancy due to risks, including Neonatal Opioid Withdrawal Syndrome (NOWS), and is not recommended for nursing mothers.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Tridol, a combination medicine containing Tramadol and Paracetamol (Acetaminophen), has a complex interaction profile primarily driven by its Tramadol component. Combining it with certain drug classes may lead to serious adverse effects.

Contraindicated and High-Risk Combinations

  • Monoamine Oxidase Inhibitors (MAOIs): Use is strictly contraindicated with MAOIs (e.g., phenelzine, selegiline) or within 14 days of discontinuing them. This combination significantly increases the risk of Serotonin Syndrome and seizures.
  • Alcohol and Central Nervous System (CNS) Depressants: Concomitant use with alcohol, benzodiazepines, hypnotics, sedatives, or general tranquilizers may result in profound sedation, respiratory depression, coma, and death. This combination should be avoided.

Other Significant Interactions

  • Serotonergic Drugs: Combining with other serotonergic medicines, such as SSRIs, SNRIs, and Tricyclic Antidepressants (TCAs), elevates the risk of Serotonin Syndrome and seizures.
  • Seizure Threshold Lowering Drugs: Co-administration with medications that lower the seizure threshold (e.g., bupropion, mirtazapine) increases the risk of convulsions.
  • Coumarin Derivatives (e.g., Warfarin): Caution is required as co-administration may cause an increase in International Normalized Ratio (INR), leading to a risk of bleeding (e.g., ecchymoses).
  • CYP3A4 and CYP2D6 Inducers/Inhibitors: Drugs that affect the metabolism of Tramadol (e.g., Carbamazepine, which reduces Tramadol's effectiveness) or Paracetamol (e.g., Cimetidine, Metoclopramide) require careful monitoring or dose adjustment. Patients should not use other products containing Tramadol or Paracetamol concurrently.

Mechanism of Action

The physiological modulation of Tridol (Tramadol) is defined by a unique dual, synergistic mechanism operating exclusively within the central nervous system. The first mechanism involves the O-desmethyl-tramadol (M1) metabolite acting as an agonist at the mu-opioid receptor (mu-OR). This activation initiates an intracellular cascade that promotes neuronal hyperpolarization and inhibits the release of specific neurotransmitters, thereby dampening the transmission of electrical signals in the spinal cord. The second, non-opioid mechanism involves the parent compound functioning as an inhibitor of the neuronal reuptake of serotonin and norepinephrine. This action increases the concentration of these monoamines in the synaptic cleft, which potentiates the monoaminergic signaling of the descending inhibitory pathway. The overall effect is the integrated central physiological modulation of nociceptive processing. The mechanism is subject to constraints: conversion to M1 is dependent on the polymorphic CYP 2D6 enzyme, and chronic mu-OR activation can lead to receptor desensitization.

Dosage and Administration Information

The administration of Tridol (Tramadol Hydrochloride) is governed by the guidelines detailed in prescribing information. The medication is used via the oral route as an immediate-release (IR) tablet or solution, or an extended-release (ER) form. It is also available for the parenteral route as an injection for intravenous, intramuscular, or subcutaneous administration in clinical settings.

For immediate-release oral forms, the standard adult dosing regimen is typically 50 mg to 100 mg taken every 4 to 6 hours, with the maximum daily dose established at 400 mg. Extended-release forms, which are designed for once-daily use, are generally initiated at 100 mg, with a total maximum limit of 300 mg per day. Regardless of the specific oral form, Tridol can be taken without regard to meals (with or without food).

A key administration rule for the extended-release form is that the tablets and capsules must be swallowed whole and must not be crushed, split, or chewed. This constraint is necessary to ensure the slow, controlled release of the ingredient over time.

Specific population guidelines mandate dose adjustments for proper use. For older adults (over 75 years) and patients with severe renal or hepatic impairment, the dosing interval for immediate-release forms must be extended (e.g., to 12 hours), and the maximum daily dose may be reduced. Guidelines also require that treatment duration be the shortest necessary and that the dose be gradually tapered upon discontinuation following long-term use.

Recent Clinical Evidence

Research evidence / Overview of Studies for Tridol

1. Evidence for Use in Chronic Low Back Pain

Research into the use of Tridol was studied for chronic low back pain. This evidence primarily consists of short-term clinical trials, applied in populations of adults experiencing chronic, moderate to moderately severe low back pain. These studies observed responses over defined time intervals, typically lasting only a few weeks to a few months. Researchers evaluated outcomes related to patient-reported outcomes describing perceived discomfort and monitored changes in outcomes reflecting daily functioning or activity level.

Systematic reviews and meta-analyses that combined these data describe patterns related to the evidence base being generally categorized as having Low Certainty. The follow-up durations for these studies were limited, restricting the ability to understand how sustained any reported patterns of symptom change might be over longer periods. As such, long-term effects are not fully established.


2. Evidence for Use in Painful Osteoarthritis

For conditions presenting with functional limitations such as painful osteoarthritis (e.g., of the knee or hip), research was evaluated in studies involving both immediate-release and extended-release versions. Studies were conducted in adults with symptomatic disease, exploring outcomes reflecting daily functioning. The certainty of the findings is often categorized as Low to Moderate. Findings across the studies were mixed and sometimes showed variability, and the overall evidence quality varies across the individual studies that were analyzed.


3. Evidence for Use in Acute Pain

Tridol was evaluated in research exploring short-term symptom changes associated with acute, disruptive episodes such as after surgery or specific dental procedures. These very short-term studies, often lasting only a few days, primarily examined outcomes describing episodic or acute changes in pain and the quantity of rescue medication required. The body of evidence was observed in some studies to be useful for exploring acute, short-term outcomes, and its certainty is observed in some studies as Moderate. Research is ongoing regarding the factors that influence the duration of use in the patient population.

Key Studies & References Tramadol (By mouth) - NIH MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Tridol (FAQ)


Q: How long does it typically take to feel the described effects of Tridol?

According to official product information, the start of relief from immediate-release forms is generally described as beginning about one hour after the dose is administered. The maximum effect of the drug is typically reached within two to three hours. Extended-release forms are formulated for a prolonged action throughout the day.


Q: If I miss a dose of Tridol, what is the general guidance on this?

Official guidance focuses on strictly maintaining the prescribed dosing schedule and never exceeding the maximum daily amount. Regulatory documents do not provide specific instruction on how to handle a missed dose, which reinforces the need to follow the prescribed regimen.


Q: What happens if I stop taking Tridol suddenly?

Regulatory documents warn that the sudden discontinuation of Tridol, especially following prolonged use, is associated with the potential for withdrawal symptoms. For this reason, official guidance recommends that the dose be gradually tapered (slowly reduced) when discontinuing the medicine.


Q: How is Tridol described in official materials regarding potential for dependence?

Official materials describe Tridol (Tramadol) as having the potential to cause both physical and psychological dependence that is characteristic of opioid-class medicines. The development of tolerance (needing more to achieve the same effect) and craving are also associated risks noted in regulatory documents.


Q: What distinguishes Tridol from other drugs that treat similar conditions?

Tridol is characterized by a unique dual mechanism of action, as described in its official clinical pharmacology documents. It acts as an opioid analgesic while also functioning as a weak inhibitor of the re-uptake of norepinephrine and serotonin. This combined approach is what sets its described action apart from other single-mechanism opioid medicines.


Q: Can Tridol cause long-term problems or issues?

Prolonged use of opioid analgesics like Tridol may influence the body’s hormone system, specifically the hypothalamic-pituitary-gonadal axis. This can potentially lead to a condition known as androgen deficiency, which may manifest as issues like low libido. The risks of tolerance and dependence are also higher with long-term use.


Q: Is it true that you can't drive while taking Tridol?

Official guidance includes warnings that Tridol may cause side effects, such as dizziness and drowsiness (somnolence), which can affect judgment and reaction time. Due to these potential effects, official guidance includes warnings regarding engaging in activities that require full mental alertness, such as driving or operating machinery.


Q: Can elderly patients use Tridol, or are there special precautions described?

Yes, elderly patients can use Tridol, but official documents note special precautions. Patients over 75 years of age are at a greater risk of serious adverse effects, such as respiratory depression. In these populations, a dose adjustment, such as extending the time between doses, is generally described as being mandated.


Q: Is Tridol a controlled substance or scheduled medication?

In the United States, Tridol (Tramadol) is classified as a Schedule IV controlled substance by the Drug Enforcement Administration (DEA). This regulatory classification recognizes its established medical use but also its lower, though still present, potential for abuse and dependence compared to higher-scheduled opioids.


Q: How long does Tridol stay in your system after the last dose?

The terminal elimination half-life of Tridol (Tramadol) is approximately 6 to 7 hours for the parent drug, according to clinical pharmacology data. The half-life describes the time it takes for half of the drug to be eliminated from the bloodstream, and complete elimination requires several half-lives.


Q: What is the general duration of Tridol's effect after one use?

The duration of effect is related to the specific formulation being used. Immediate-release forms are typically prescribed for use every 4 to 6 hours, while extended-release forms are designed to slowly release the medication for an analgesic effect that lasts approximately 24 hours.


Q: What is the risk classification of Tridol during pregnancy?

Tridol has historically been classified as Pregnancy Category C by the FDA. Official warnings stress that prolonged use during pregnancy can result in the Neonatal Opioid Withdrawal Syndrome (NOWS), a condition that may require specialized care in the newborn.


Q: Does Tridol interact with common over-the-counter pain relievers?

Regulatory warnings focus on drug classes. Co-administration with other medicines that may lower the seizure threshold increases the risk of convulsions. Official information also mentions that caution is noted when combining Tridol with coumarin derivatives (a class of blood thinners).


Q: Are there any known interactions between Tridol and herbal supplements?

Official documents explicitly warn about combining Tridol with any serotonergic drugs, such as certain prescription antidepressants, because of the risk of Serotonin Syndrome. While specific herbal names are not usually listed, any supplement with known serotonergic activity (e.g., St. John's wort) is noted as carrying a potential risk.


Q: Is Tridol used for purposes other than what is commonly known?

Tridol is approved by regulatory authorities for the treatment of moderate to moderately severe pain in adults. Any application outside of this specific regulatory indication is considered off-label and is not addressed in the official prescribing information.


Q: Do studies suggest Tridol loses effectiveness over time?

Official documentation notes that with repeated use, the minimum effective analgesic concentration for a patient may increase over time. This clinical observation is described as the development of analgesic tolerance, which is a noted risk associated with the medication.


Q: What should I look for in the official patient information leaflet for Tridol?

The official Medication Guide or leaflet will contain critical information on the proper use and storage of the drug. It also emphasizes the serious risks, including respiratory depression and dependence, and provides guidance on how to recognize and report the most serious adverse reactions.


Q: Is there a specific time of day when Tridol should be used?

The timing depends on the form used. Immediate-release tablets are prescribed as needed every 4 to 6 hours, while extended-release forms are typically prescribed for use once daily. Official documents state that the drug can generally be taken with or without food.


Q: Are there restrictions on activities mentioned in official guidance for Tridol users?

Yes, due to the risk of side effects like dizziness and somnolence (drowsiness), official guidance advises caution regarding engaging in activities that require full mental alertness. This includes driving or operating heavy machinery until the effect of the medicine is understood.


Q: Does Tridol affect sleep patterns, according to regulatory documents?

Official documentation lists somnolence (drowsiness) as a Common adverse reaction. While the effects on overall sleep architecture (like insomnia) are not always detailed in the primary documents, the potential effect on daytime wakefulness is clearly noted in the safety profile.


Q: Can Tridol cause psychological side effects like mood changes?

Official documentation lists Confusion and Hallucinations as Rare adverse reactions associated with the use of Tridol. Other central nervous system effects such as anxiety, agitation, and nervousness may also be noted in the less frequent categories of adverse events.


Q: What do official sources say about using Tridol long-term?

Official sources caution that the duration of treatment should be the shortest necessary for the condition being managed. Long-term use is specifically associated with increased risks of tolerance, physical and psychological dependence, and potential endocrine effects.


Q: Can Tridol be taken with other prescription medicines for chronic conditions?

Official documents describe significant interactions with several classes of prescription medicines used for chronic conditions, such as anticoagulants and certain antidepressants. The existence of these potential interactions highlights the importance of reviewing all prescription medicines when using Tridol.


Q: What happens if Tridol is used by someone who shouldn't take it?

Using Tridol in populations where it is contraindicated (e.g., patients taking MAOIs or those with acute CNS depressant intoxication) significantly elevates the risk of life-threatening adverse effects. These severe reactions include respiratory depression and Serotonin Syndrome.


Q: Are there gender-specific considerations for Tridol use noted in official sources?

Official clinical data notes minor differences in the volume of distribution (how the drug spreads in the body) between male and female subjects. Additionally, the chronic use of opioids is stated to potentially influence the hormone system in both men and women.


Q: What is the maximum described period of time Tridol can be used?

Official guidance emphasizes that the duration of treatment should be the shortest necessary and does not specify a maximum time limit. However, the risk of dependence, tolerance, and endocrine issues is noted to increase with prolonged use.


Q: Does Tridol have a black box warning in the US, and if so, what does it cover?

Yes, Tridol (Tramadol) carries a Boxed Warning on the US FDA label, which is the agency’s strictest warning. It covers several serious risks, including the potential for Addiction, Abuse, and Misuse; Life-Threatening Respiratory Depression; and the risk of Neonatal Opioid Withdrawal Syndrome (NOWS).


Q: Is the effect of Tridol immediate, or does it build up over time?

For immediate-release forms, the analgesic effect begins within one hour of the first dose. However, when used as a regularly scheduled medicine, steady-state concentrations (the continuous level of drug in the body) are typically achieved within two days.

How should Tridol be stored and disposed of?

How to Store and Dispose of Tridol (Tramadol)

The storage and disposal of Tridol are governed by official requirements to maintain the drug's integrity and ensure public safety.


Storage Requirements

Condition Requirement (Official Labeling)
Child Safety Must be kept out of the sight and reach of children (Mandatory).
Container Store in the container it came in and keep the container tightly closed.
Oral Forms Store at room temperature, away from excess heat and moisture (e.g., not in the bathroom).
Injection Must not be stored above 30^circC and must not be refrigerated or frozen.
Stability Opened injection ampoules should be used immediately. Diluted solutions have limited in-use stability (e.g., 48 hours at 25^circC).

Disposal Instructions

  • Preferred Method: The primary method is immediate disposal via a drug take-back program or authorized collection site.
  • Alternative: If a take-back option is unavailable, specific tramadol products on the FDA's flush list should be immediately flushed down the toilet to prevent accidental ingestion.
  • General: Unused medicinal product must be disposed of in accordance with local requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tridol found in:

A-Z Index: